Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cs 023
2. Cs-023
3. Cs023 Cpd
4. R 115685
5. R-115685
6. R115685
7. Ro4908463
1. 222400-20-6
2. Cs-023
3. Ro-4908463
4. R-1558
5. R-115685
6. R-1l5685
7. Ro4908463
8. Antibiotic Cs 023
9. 1654w9611t
10. R115685
11. (4r,5s,6s)-3-[(3s,5s)-5-[(3s)-3-[[2-(diaminomethylideneamino)acetyl]amino]pyrrolidine-1-carbonyl]-1-methylpyrrolidin-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
12. 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, 3-(((3s,5s)-5-(((3s)-3-((((aminoiminomethyl)amino)acetyl)amino)-1-pyrrolidinyl)carbonyl)-1-methyl-3-pyrrolidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-, (4r,5s,6s)-
13. Tomopenem [usan]
14. Tomopenem [usan:inn]
15. R 115685
16. Ro 4908463
17. R 1558
18. Unii-1654w9611t
19. (4r,5s,6s)-3-(((3s,5s)-5-((s)-3-(2-guanidinoacetamido)pyrrolidine-1-carbonyl)-1-methylpyrrolidin-3-yl)thio)-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[
20. Cs 023
21. Tomopenem [inn]
22. Cs023 Cpd
23. Tomopenem (usan/inn)
24. Tomopenem [who-dd]
25. Schembl304829
26. Chembl389847
27. Gtpl10869
28. Dtxsid70873384
29. Cs023
30. Zinc3993831
31. Bdbm50483019
32. Hy-123022
33. Cs-0079886
34. D09022
35. Q15427876
36. (1r,5s,6s)-2-[(2s,4s)-2-[(3s)-3-(2-guanidinoacetylamino)pyrrolidin-1-ylcarbonyl]-1-methylpyrrolidin-4-ylthio]-6-[(1r)-1-hydroxyethyl]-1-methyl-1-carbapen-2-em-3-carboxylic Acid
37. (1r,5s,6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2-[(2s,4s)-2-[(3s)-3-(2-guanidinoacetylamino)pyrrolidin-1-ylcarbonyl]-1-methylpyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylic Acid
38. (4r,5s,6s)-3-(((3s,5s)-5-(((3s)-3-((2-guanidinoacetyl)amino)pyrrolidin-1-yl)carbonyl)-1-methylpyrrolidin-3-yl)sulfanyl)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid
39. (4r,5s,6s)-3-(((3s,5s)-5-((3s)-3-(carbamimidamidoacetamido)pyrrolidine-1-carbonyl)-1-methylpyrrolidin-3-yl)sulfanyl)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid
40. (4r,5s,6s)-3-(((3s,5s)-5-((s)-3-(2-guanidinoacetamido)pyrrolidine-1-carbonyl)-1-methylpyrrolidin-3-yl)thio)-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
41. (4r,5s,6s)-3-[(3s,5s)-5-[(3s)-3-[(2-guanidinoacetyl)amino]pyrrolidine-1-carbonyl]-1-methyl-pyrrolidin-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
42. (4r,5s,6s)-3-{[(3s,5s)-5-{[(3s)-3-{[n-(diaminomethylidene)glycyl]amino}pyrrolidin-1-yl]carbonyl}-1-methylpyrrolidin-3-yl]sulfanyl}-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
| Molecular Weight | 537.6 g/mol |
|---|---|
| Molecular Formula | C23H35N7O6S |
| XLogP3 | -3.7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 8 |
| Exact Mass | 537.23695304 g/mol |
| Monoisotopic Mass | 537.23695304 g/mol |
| Topological Polar Surface Area | 220 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1050 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Cs 023 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cs 023, including repackagers and relabelers. The FDA regulates Cs 023 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cs 023 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cs 023 supplier is an individual or a company that provides Cs 023 active pharmaceutical ingredient (API) or Cs 023 finished formulations upon request. The Cs 023 suppliers may include Cs 023 API manufacturers, exporters, distributors and traders.
click here to find a list of Cs 023 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cs 023 DMF (Drug Master File) is a document detailing the whole manufacturing process of Cs 023 active pharmaceutical ingredient (API) in detail. Different forms of Cs 023 DMFs exist exist since differing nations have different regulations, such as Cs 023 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cs 023 DMF submitted to regulatory agencies in the US is known as a USDMF. Cs 023 USDMF includes data on Cs 023's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cs 023 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cs 023 suppliers with USDMF on PharmaCompass.
Cs 023 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cs 023 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cs 023 GMP manufacturer or Cs 023 GMP API supplier for your needs.
A Cs 023 CoA (Certificate of Analysis) is a formal document that attests to Cs 023's compliance with Cs 023 specifications and serves as a tool for batch-level quality control.
Cs 023 CoA mostly includes findings from lab analyses of a specific batch. For each Cs 023 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cs 023 may be tested according to a variety of international standards, such as European Pharmacopoeia (Cs 023 EP), Cs 023 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cs 023 USP).
LOOKING FOR A SUPPLIER?
